자주 묻는 질문

What is Idecabtagene Vicleucel used for?

This CAR-T cell therapy targets BCMA on multiple myeloma cells, offering treatment for relapsed or refractory disease.

Is Idecabtagene Vicleucel an approved drug?

Yes, Idecabtagene Vicleucel is an approved drug. It has reached clinical phase 4. It is classified as a Gene.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

• ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4298199. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.